NEOL Biosolutions, S.A. (BME:NEOL) announced that it intends to conduct a private placement of common shares for gross proceeds of €3,000,000 on June 29, 2016. The company has signed a memorandum of understanding with a new investor, Black Toro Capital LLP. The completion of the transaction is subject to a due diligence process.